semaglutide goodyear Medical Weight Loss Program AZ, GLP-1 Medication, & Tirzepatide Weight Loss Success: Semaglutide and

Studies have shown obese individuals show resistance to the hormone leptin, responsible for feeling full

They are part of a larger group of incretin mimetics

Caffeine consumed within 6 hours of bedtime can significantly impair sleep quality

We have seen that oral GLP-1 agonists alone are often insufficient to generate such significant results but using them as a tool to augment the results of the Allurion Program could be a promising treatment approach in the future. Allurion recently published findings indicating that providers are interested in combining the Allurion Program with anti-obesity medications and that the rise of GLP-1 agonists has increased patient inquiries and boosted awareness of weight loss treatments like the Allurion Program